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Iron meatbolism in animals is altered by haemolytic anaemia induced by phenylhydrazine (PHZ). In common with a number of other
modulators of iron metabolism, the mode and the mechanisms of this response are yet to be determined. However, recent studies have shown
increased expression of the ferrous transporter DMT1 in the duodenum and other tissues of mice administered PHZ. We examined the
expression of the ferric reductase Dcytb, DMT1 and some other genes involved in Fe metabolism in tissues of mice dosed with PHZ. The
expression of iron-related genes in the duodenum, liver, and spleen of the mice were evaluated using Northern blot analyses, RT-PCR and
immunocytochemistry. Dcytb, and DMT1 mRNA and protein increased markedly in the duodenum of mice given PHZ. The efflux protein
Ireg1 also increased in the duodenum of the treated mice. These changes correlated with a decrease in hepatic hepcidin expression. Dcytb,
DMT1, Ireg1 and transferrin receptor 1 mRNA expression in the spleen and liver of mice treated with PHZ responded to the enhanced iron
demand associated with the resulting stimulation of erythropoiesis. Enhanced iron absorption observed in PHZ-treated animals is facilitated
by the up-regulation of the genes involved in iron transport and recycling. The probable association of the erythroid and the store regulators
of iron homeostasis and absorption in the mice is discussed.
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Mammals maintain iron metabolism by regulating dis-
tribution between the sites of demand and storage and
absorption at the level of the enterocyte [1]. No excretory
mechanism for iron exists apart from obligatory losses
through desquamation [2] and apoptosis of apical epithelial
cells [3]. Hence, intestinal iron absorption is a tightly
regulated physiological process. Brush border mucosal
uptake, intracellular processing and basolateral efflux of0925-4439/$ - see front matter D 2004 Published by Elsevier B.V.
doi:10.1016/j.bbadis.2004.06.011
Abbreviations: Dcytb, duodenal cytochrome b; DMT1, divalent metal
transporter 1; Ireg1, iron regulated mRNA; TFR1, transferrin receptor 1;
HO1, haem oxygenase 1; EPO, erythropoeitin; hepcidin, heph, hephaestin;
IRE, iron response element; IRP, iron regulatory protein
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involved in this pathway. These in turn are determined by
the signals received from the utilization and reservoir status
often referred to as the erythroid and store regulators of iron
absorption, respectively [4]. Consequently, these two factors
determine the rate at which iron is absorbed by influencing
the expression of key proteins in duodenal enterocytes. The
origin of these stores and erythroid demands for iron is,
however, remote from the intestine and has led to the search
for mechanisms to explain communication of iron require-
ments between body tissues and the coordination of tissue
responses. Recently, a liver-secreted peptide, hepcidin, has
been implicated as a regulator of iron absorption [5,6].
While iron absorption has been shown to increase
following phenylhydrazine (PHZ)-induced anaemia [7,8],
the genetic and molecular events associated with this model
have not been elucidated. In order to further investigateta 1690 (2004) 169–176
Table 1
Primer sequences
Dcytb 5V-CCA GAC CAC TAT ACA TGT CC-3V
5V-CTC ACT GCT TGA CTC TGC-3V
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studied the responses of iron-regulated genes at the mRNA
level in this drug-induced acute haemolytic anaemic
condition in various tissues in mice.
DMT1-IRE 5V-GCA AAA ATA ACA GCA GCC CC-3V
5V-CCA ATG CAA TCA AAC ACT GCC-3V
Ireg1 5V-CTT ACA GCC TCA TTT ATC ACC ACC G-3V
5V-AGA GGA GAG GGA TGG GGT GTG GTA T-3V
TFR1 5V-CTC CAT AGA GTT TGC TGA CAC C-3V
5V-CAG TTC CTA GAT GAG CAT GTC C-3V
heph 5V-ATG CTC TTT CCT CAC ACC-3V
5V-CCA GAC CAC TAT ACA TGT CC-3V
Hepcidin 5V-GCT TCT CCT CCT TGC CAG CCT GAG G-3V
5V-AAT CGT CTT TAT TTC AAG GTC ATT G-3V
EPO 5V-AGC AAG AAG AGA GAG TCT GTC C-3V
5V-ATA AGC TAA ACC AGT GTC ATC C-3V
HO1 5V-ACA CAG CAC TAT GTA AGG C-3V
5V-AGA GAA AGG AAA CAC AGG-3V
Beta-actin 5V-CAA CCG TGA AAA GAT GAC C-3V
5V-TAC TCC TGC TTG CTG ATC C-3V
18S 5V-GAA TTC CCA GTA AGT GCG GG-3V
5V-GGG CAG GGA CTT AAT CAA CG-3V2. Materials and methods
2.1. Animals and tissue collection
CD1 mice were used for all experiments. All procedures
were approved and conducted in accordance with the UK
Animals (Scientific Procedures) Act, 1986. Two intraper-
itoneal injections of neutralised PHZ (60 mg/kg body
weight) were performed on 2 consecutive days. Three days
later, blood was collected by cardiac puncture of anaes-
thetised mice using heparin as anticoagulant. Reticulocyte
counts were performed after staining with new methylene
blue.
2.2. Iron Absorption
Iron absorption was measured in vivo in tied-off loop
segments of the duodenum as previously described [9]. A
small volume (50 Al) of the 59Fe3+-nitrilotriacetate was
administered intraluminally. After 10 min, the animal was
killed and the duodenal segment removed, flushed with
saline and freed of any connective and pancreatic tissues.
The segment was weighed and its radioactivity was
determined in a gamma-counter (LKB Wallac 1280,
Helsinki, Finland). The radioactivity in the carcass gives a
measure of 59Fe3+ transfer to the plasma. The sum of
retention and transfer to the carcass is the total mucosal
uptake of Fe.
2.3. Northern Blot and RT-PCR
Total RNA was extracted from tissue samples using
TRIZOL reagent (Invitrogen, UK) according to manufac-
turer’s instructions. Northern blotting was carried out as
previously described [10] by using 20 Ag of total RNA.
RNA from the tissues was denatured in formaldehyde-
containing buffer and electrophoresed in 1% agarose/form-
aldehyde gels. RNA from the gels was transferred on to a
nylon membrane (Gene-Screen Plus, Dupont-NEN, Boston,
MA, USA). In some experiments, gene expression was
determined using reverse transcriptase-PCR as previously
described [11]. PCR was performed for 25–30 cycles of 94
8C for 1 min, 94 8C 10 s, 55–60 8C annealing and 72 8C for
2 min as extension time in a PTC-200 DNA Engine thermal
cycler (MJ Research). PCR products were stained with
ethidium bromide on a 1% agarose gel and visualised. The
intensities of the bands were quantified and values
normalised to beta-actin or 18S levels. Sequences of primers
used, forward and reverse, respectively, are as shown in
Table 1.2.4. Iron and protein determinations
Quantification of liver iron levels was carried out as
previously described [12] and protein concentrations were
determined using the Bradford assay (Bio-Rad).
2.5. Immunohistochemistry
Dcytb, DMT1 and Ireg1 protein expressions were
localised by immunofluoresce microscopy in frozen sections
of duodenal tissues snap frozen in OCT as previously
described [10].
2.6. Statistical analysis
All values are expressed as meanFS.E. Statistical
differences between means were calculated with Microsoft
Excel 6.0 (Microsoft, Seattle, WA) by using the Student’s t
test correcting for differences in sample variance. Data are
meansFS.E. of four to eight mice.3. Results
3.1. Indices of haemolysis and iron absorption in the
experimental mice
Haemolytic anaemia induced by PHZ has been shown to
cause increased iron absorption in experimental animals [7].
PHZ causes haemolysis, which stimulates erythropoietin-
mediated erythropoiesis in the bone marrow and the spleen.
The increase of erythropoiesis was measured by reticulocyte
counts in blood samples, splenomegaly (spleen index) and
erythropoietin expression in kidneys of the treated and
control mice. Significant reticulocytosis and splenomegaly
were seen in PHZ-treated mice. Reticulocyte counts and
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(control) and 46.9%F4.8 (PHZ) and 0.97F0.052 (control)
and 1.49F0.032 (PHZ) (n=7). Erythropoietin expression,
measured by Northern blot, was significantly increased in
the kidney of PHZ-treated mice; values in arbitrary units
were 0.41F0.05 and 0.64F0.04 (Pb0.01), respectively, for
the controls and treated mice. Iron levels increased twofold
in the livers of the PHZ-treated mice; values were
3.07F0.57 and 6.01F0.75 nmol/mg (wet) tissue, respec-
tively, for the controls and treated mice. Iron absorption was
significantly increased (about twofold) 3 days after PHZ
administration to the mice (Fig. 1). Both iron uptake and
transfer processes were enhanced in the mice.
3.2. Expression of iron-related genes in the duodenum of
mice treated with PHZ
To investigate the molecular basis of the increased iron
absorption that accompanies PHZ-induced haemolysis, we
studied the expression of iron transport genes in the
duodenum of treated animals (Fig. 2). The expression of
Dcytb, DMT1-IRE and Ireg1 mRNA was enhanced in the
duodenum of PHZ-treated mice, although the increase
observed with Ireg1 did not reach statistical significance at
the 0.05 level. However, hephaestin mRNA expression was
not significantly different between PHZ-treated and control
mice. This is consistent with previous observations on the
regulation of hephaestin by varying iron status of exper-
imental animals [12]. The patterns of gene expression in the
duodenum were also confirmed by RT-PCR analyses (Fig.
2c and d).Fig. 1. Iron absorption in mice injected with PHZ. Two intraperitoneal
injections of neutralised PHZ (60 mg/kg body weight) were performed on 2
consecutive days. Control mice received equivalent volume of sterile 0.15
M NaCl. Iron absorption (as described in Section 2) was performed 3 days
after the administration of PHZ (meanFS.E., n=3 Pb0.05).3.3. Protein expression of the iron regulated genes in the
duodenum
Using immunocytochemistry Dcytb, DMT1 and Ireg1
protein expressions were increased in the duodenum of mice
injected with PHZ (Fig. 3). In the case of Dcytb, strong
apical staining of the duodenal enterocytes was evident.
3.4. Expression of iron-related genes in the spleen of mice
given PHZ
DMT1 has been shown to be expressed and regulated by
iron status in tissues other than duodenum [13]. As Dcytb
and Ireg1 are also presumed to be involved in iron
metabolism in other tissues, we measured expression of
these genes in spleen and liver of the PHZ-treated mice. The
catabolic and anabolic pathways of haemoglobin in the
spleen during a period of acute haemolysis must be co-
ordinately regulated to effect a balance in systemic iron
homeostasis; we therefore measured the expression of
transferrin receptor (TFR1) and haem oxygenase (HO1) as
well as iron transport molecules. HO1 is an important
inducible enzyme involved in haem degradation [14] and
perhaps iron efflux from cells [15]. Ireg1, TFR1 and HO1
expressions were increased in the spleen of the PHZ-treated
mice (Fig. 4a and b). Dcytb levels in spleen were also found
to be increased in PHZ-treated mice (Fig. 4 c and d). mRNA
levels for both IRE and non-IRE forms of DMT1 were
increased in spleen of PHZ-treated mice (Fig. 4 e and f).
Previous studies have shown enhanced DMT1 protein
expression [16] and, in particular, the non-IRE mRNA
isoform [17] in the spleen of mice treated with PHZ. This
perhaps reflects a priority of a local demand and supply of
Fe for the increased erythropoeitic activity of the spleen.
3.5. Expression of iron-related genes in the liver of PHZ-
treated mice
Recent data have suggested that the liver plays an
important role in maintaining body iron homeostasis. Thus,
we examined the hepatic expression of several relevant
genes following PHZ-induced haemolysis. While TFR1
expression was significantly increased in PHZ-treated mice,
DMT1-IRE was down-regulated. Ireg1 expression was
slightly increased in the livers of the treated mice (Fig. 5),
while hepcidin expression was decreased (Fig. 6).4. Discussion
4.1. Uptake, efflux and the regulation of iron absorption in
the duodenum
The absorption of iron occurs predominantly in the
duodenum where the mucosa remains attuned to the
prevailing requirement of the body for the metal [18]. An
Fig. 3. Dcytb, DMT1 and Ireg1 protein expressions in duodemun after PHZ administration. Duodenal sections frozen in OCT were analysed by
immnunofluorescence using the respective polyclonal antibodies. (For color see online version).
Fig. 2. Expression of iron-metabolism genes in the duodenum of PHZ-treated mice. (a) The figure shows triplicate samples on a representative Northern blot.
Twenty micrograms of total RNAwas electrophoresed, blotted and hybridised as described in Section 2. (b) Band intensities were quantified by densitometry
and the relative gene expression, normalised with 18S RNA, is shown in the graphs. Results are expressed as meanFS.E. of four to eight mice and statistical
analysis was performed using the Student’s t test (unpaired, two tailed), *Pb0.05. (c) Level of the specific genes in the duodenum as measured by RT-PCR
(described in Section 2), and the amplified products were separated by electrophoresis and visualised with ethidium bromide. (d) Relative expressions of the
genes in the RT-PCR bands were quantified by densitometry and normalised with 18S ribosomal RNA.
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Fig. 4. Expression of iron-metabolism genes in the spleen of mice treated with PHZ. (a) Representative reverse transcription-PCR analysis of the effect
of PHZ treatment on Ireg1, TFR and HO mRNA expression in mouse spleen samples. (b) Band intensities were quantified by densitometry and the
relative gene expression, normalised with 18S ribosomal RNA, is shown in the graph. (c) Representative reverse transcription-PCR analysis of the
effect of PHZ treatment on Dcytb mRNA expression in mouse spleen samples. (d) Band intensities were quantified by densitometry and the relative
gene expression, normalised with beta-actin, is shown in the graph. (e) Northern Blot analysis of 20-Ag RNA of spleen tissues for DMT1 IRE and
NIRE. (f) Band intensities were quantified by densitometry and the relative gene expression, normalised with beta-actin, is shown in the graph.
Results are expressed as meanFS.E. of three to four mice and statistical analysis was performed using the Student’s t test (unpaired, two-tailed),
*Pb0.05.
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Fig. 5. Expression of iron-related genes in the liver of PHZ-treated mice. (a) Total RNAwas extracted from liver samples and gene expression was determined
by Northern blotting. Twenty micrograms of total RNA was electrophoresed, blotted and hybridised as described in Section 2. (b) Band intensities were
quantified by densitometry and the relative gene expression, normalised with beta-actin, is shown in the graph. Results are expressed as meanFS.E. of four to
eight mice and statistical analysis was performed using the Student’s t test (unpaired, two-tailed), *Pb0.05.
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electrical driving force for iron uptake across the duodenal
brush border has been shown as an important adaptation for
increased iron absorption in PHZ-induced haemolytic
anaemia in both rats [19] and humans [20]. We found that
RNA transcripts and protein of DMT1 and Dcytb increased,
presumably to meet the high iron requirements associated
with the increased erythropoeitic activity of the spleen and
bone marrow in mice treated with PHZ. The increase in the
transcripts of these genes could be due to local regulation by
the iron concentration of the mature enterocytes or
modulation via systemic signals. Finch et al. [21] reported
that a relative iron deficiency state occurs when the erythron
iron requirements exceed the available supply of iron, even
in the presence of storage iron. Thus, cytosolic ironFig. 6. Hepcidin expression in the liver of PHZ-treated mice. (a) Hepcidin mRNA l
blot analysis. A representative blot is shown. (b) Relative changes in hepcidin mRN
represent the meanFS.E. for eight mice. *Pb0.01.depletion might activate the iron regulatory proteins (IRP1
and IRP2) to bind and stabilise the mRNA transcripts of
DMT1 (IRE) and Ireg1. Both contain IRE motifs [22],
although it appears that Ireg1 is regulated by different
mechanisms in the liver and gut.
While the mechanism of IRP-IRE function has not been
clearly defined even in the case of Ireg1, Dcytb does not
appear to possess a recognisable IRE, even though it is
regulated by iron [10]. Hence, it is probable that other
regulatory mechanisms co-ordinate the expression and
localisation of proteins involved in iron absorption. Kinetic
analysis of intestinal iron transport in acutely haemolysed
mice has shown that both uptake and transfer are increased
[23,24]. Recently, down-regulation of hepcidin has been
implicated in the regulation of iron absorption in miceevels in the liver of control and PHZ-treated mice as determined by Northern
A levels normalised with h-actin values (arbitrary units) were plotted. Data
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reductions in the levels of hepcidin transcripts during
haemolytic anaemia induced by PHZ. Previous work did
not, however, include data on iron absorption rates or
expression of iron genes in the same mice or mice subjected
to the same dose of PHZ. While the exact mode and
mechanism of hepcidin action is yet to be determined, it is
remarkable that this signalling molecule communicates
between the iron absorptive, utilisation and storage compart-
ments in the organism. It has been suggested that hepcidin
levels might reflect the rate of iron turnover in the body by
sensing changes in the level of diferric transferrin and
therefore provide the link between iron requirements and
absorption from the diet [26]. Frazer et al. [12] demonstrated
that transferrin saturation correlated tightly with the
expression of the keys genes involved in iron transport
and metabolism. Transferrin saturation is perhaps one of the
mechanisms by which hepcidin expression is regulated,
however, serum iron has been found to be increased in PHZ-
treated mice [25].
4.2. Iron mobilisation, utilisation and storage in the spleen,
reticulocytes and liver
Iron supply to the bone marrow when erythropoiesis is
stimulated comes from both the RE system (recycled red
cell haemoglobin derived iron) and from increased absorp-
tion. A significant proportion of plasma iron is partitioned
into erythroblasts in the bone marrow for haemoglobin (Hb)
biosynthesis. Iron is rapidly cleared from the plasma in
acute haemolytic anaemias leading to increased egress of
iron from mucosal cells into the plasma for delivery to the
bone marrow. When increased erythropoeisis is also
associated with haemolysis, increases in Hb catabolism
generate an increased amount of iron in the reticuloendo-
thelial system (RES) of the liver and spleen [27]. Our study
showed that there was increased HO1 mRNA levels in the
spleen of PHZ-treated mice, suggesting that there is
adaptation of the capacity for heme degradation in the
spleen, when massive haemolysis is induced. Recent studies
indicate that the transporter Ireg1 also mediates the major
efflux pathway in peripheral tissues [28,29]. Consequently,
Ireg1 expression tended to increase in the liver of mice
treated with PHZ. Since the spleen from these mice is also
highly erythropoietic, the expression of DMT1 and TFR1 is
elevated to supply iron to the developing red blood cells.
This is clearly evident in the RT-PCR analyses. As the
expression of the two different isoforms of DMT1 and
TFR1 is tissue-specific, much more complex iron respon-
sive regulation seems to occur in both the liver and the
spleen. Dcytb expression was also increased by PHZ
treatment in spleen, however, the precise role of this protein
in spleen requires further studies.
The present data show that expression of iron transport
and metabolism genes occurs in a coordinated fashion in
several tissues of mice in response to PHZ treatment. Theprecise molecular mechanisms responsible for this presum-
ably include hepcidin, cellular iron levels, erythropoietin
and perhaps unknown factors.Acknowledgements
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